SCHEMBL5016594

SCHEMBL5016594

CCN(Cc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC)[C@H](C)C(=O)O.CCN=C(C)C(=O)NCc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC

nearest known ligand 0.63

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EGFR P00533 20/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5022993 1.00 EGFR (0.63) EGFR
SCHEMBL4441308 0.91 EGFR (0.74) EGFR
SCHEMBL4446647 0.91 EGFR (0.74) EGFR
SCHEMBL5025540 0.89 EGFR (0.71) EGFR
SCHEMBL5016635 0.89 EGFR (0.71) EGFR
SCHEMBL5026764 0.89 EGFR (0.71) EGFR
SCHEMBL5025442 0.86 EGFR (0.58) EGFR
SCHEMBL5026721 0.85 EGFR (0.57) EGFR
SCHEMBL4441245 0.84 EGFR (0.84) EGFR
SCHEMBL4449259 0.84 EGFR (0.84) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1713781-B1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2008-11-05 EP disclosed